News
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
6d
Green Matters on MSNOzempic Sparks Both Weight Loss Success Stories and Major Lawsuits in 2025
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results